dr. martin on sct-related toxicities for patients with mcl
Published 7 years ago • 72 plays • Length 0:49Download video MP4
Download video MP3
Similar videos
-
1:02
dr. martin on intensive therapy for young patients with mcl
-
1:11
dr. martin on patient preferences with mcl treatment
-
0:43
dr. martin on potential for car t-cell therapy in mcl landscape
-
2:34
dr. martin discusses the heterogeneity of mcl
-
1:20
dr. martin on the frontline treatment landscape of mcl
-
3:53
treatment approaches for older patients with mcl
-
0:48
dr. martin on the role of transplant in mantle cell lymphoma
-
9:02
martin dreyling, md: efficacy of first-line ibrutinib in mcl
-
10:42
understanding mantle cell lymphoma with jia ruan, md, ph.d.
-
42:34
mantle cell lymphoma treatment (and clinical trial) | jason’s story | the patient story
-
21:28
mantle cell lymphoma | oncology today with dr neil love: role of btk inhibitors in patients with ...
-
0:57
dr. rule on treatment of young, fit patients with mcl
-
42:29
mantle cell lymphoma (case studies)
-
1:14:44
taking the leap with innovative strategies in mcl
-
1:22
dr. rule on searching for a biomarker indicating indolent mcl
-
1:58
copanlisib for people with mcl previously treated with ibrutinib
-
1:15
dr. leonard on rituximab maintenance strategy for patients with mcl
-
2:08
dr. peter martin on future treatment approaches in mantle cell lymphoma
-
1:21
exploring targeted and car t-cell therapies on the horizon for mcl
-
1:25
dr. lee on early efficacy data with cirmtuzumab/ibrutinib in relapsed/refractory mcl
-
1:37
expert reviews treatment landscape for patients with mantle cell lymphoma
-
1:31
dr. goy on treating older patients with mcl